BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services

Atmo Biosciences achieves patient recruitment target for dysmotility pivotal clinical study

Atmo Biosciences, a company commercializing the world’s first ingestible gas-sensing capsule that provides insights into gut health and microbiome fu...

December 14, 2023 | News

WuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader

The three-day comprehensive audit covered the CDMO site's drug substance (DS) facility, drug product (DP) facility, QC laboratories, warehouse, and utiliti...

December 07, 2023 | News

Merck Expands Newest Biologics Testing Center in Shanghai

Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million...

November 30, 2023 | News

WuXi Biologics Achieves Breakthrough Productivity of ~6 g/L/day in Integrated Continuous Process at Pilot Scale

By leveraging WuXiUPTM, WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing from perfused cell culture...

November 23, 2023 | News

WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange

WuXi XDC issued a total of 178,446,000 shares under the global offering at an offer price of HK$20.60 per share (being the high-end of the indica...

November 20, 2023 | News

Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma

The company can initiate a project on four continents and easily transfer validated methods across labs, allowing therapeutic trials to extend to virtually...

November 03, 2023 | News

Samsung Biologics and Kurma Partners Forge Biologics Development & Manufacturing Alliance for Kurma's Portfolio

- Samsung Biologics to provide de-risking, development, manufacturing services, and seamless transitions for biologics from early stages of developmen...

October 25, 2023 | News

XINGIMAGING and MITRO BIOTECH Merge for Global CRO Operations

As a combined company, Mitro will expand its capabilities to provide full CRO services, including clinical and clinical imaging management, in China&n...

October 24, 2023 | News

Aragen Commissions state-of-the-art Formulations Manufacturing Facility in India

This state-of-the-art facility, set up at an investment of USD 3Mn, is located at the Mallapur Campus in Hyderabad and spans over 12,000 square feet area. ...

October 20, 2023 | News

Vetter Looks Ahead to Further Expansions to Meet Supply Chain Demand

Ongoing investments in the supply chain for complex injectable medications Committed to sustainable growth and long-term planning Dedicated to making i...

October 18, 2023 | News

Fujirebio and Sysmex Enter into Basic Agreement on Business Collaboration in the Field of Immunoassay

Sysmex has built up a robust technological foundation as well as a global network in the in vitro diagnostics field through developing its busine...

October 11, 2023 | News

Dirk Lange Reveals Merck's Historic Leap as the First CTDMO to Offer Integrated mRNA Services: A Blueprint for Advancing Biopharma

In this interview, we explore the significance of Merck's €1 billion investment in advancing mRNA technologies, the impact of their acqu...

October 11, 2023 | News

Emmes acquires VaxTRIALS

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical inn...

October 06, 2023 | News

WuXi Bio Applauds Amicus on FDA Approval for Pompe Disease Therapy

Pombiliti™, a recombinant human GAA enzyme (rhGAA) naturally expressed with high levels of bis-M6P (Mannose 6-Phosphate), was started at WuXi Biologi...

October 02, 2023 | News

Stay Connected